tiprankstipranks
Orpea SA (FR:EMEIS)
:EMEIS
France Market

Orpea SA (EMEIS) Earnings Dates, Call Summary & Reports

29 Followers

Earnings Data

Report Date
Sep 30, 2026
TBA (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
Last Year’s EPS
-0.85
Same Quarter Last Year
Moderate Sell
Based on 1 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Apr 08, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed a strong operational recovery and major balance-sheet repair in FY2025: robust organic revenue growth, rising occupancy, significant margin expansion, positive free cash flow and sizable disposals combined with a full refinancing that materially reduced net debt and leverage. These positives are tempered by continued reported net losses driven by elevated nonrecurring items and depreciation, some country-specific underperformance (notably Ireland and clinics), and remaining interest‑rate exposure until hedging is completed. On balance, the improvements materially outweigh the remaining issues and management expressed confidence and concrete near-term targets.
Company Guidance
The company guided that EBITDA should grow at least 10% in 2026 at constant perimeter, supporting a >15% CAGR for 2024–26 (management repeatedly stated “at least 15%” for that period) and reaffirmed mid‑term EBITDAR growth of roughly 12–16% on average for 2024–28; this outlook rests on the 2025 performance (like‑for‑like revenue +6.1%, nursing homes +8.1%, occupancy +1.8 points to 87.6% and nursing‑home occupancy 87.2%), strong cash generation (net operating cash flow €190m, free cash flow €347m), large disposals (€2.35bn achieved, ~€216m still signed), materially reduced net debt (pro‑forma ~€3.8bn, c.€1bn down year‑on‑year) and leverage improvement (pro‑forma 9.9x now, target to fall below 6.5x by end‑2029; 2026 covenant 12x); management also expects non‑recurring items to normalize (2025: €126m → c.€40–50m in 2026) and says it will be selective on further disposals while continuing operational improvements.
Strong organic revenue growth
Group revenue grew +6.1% like-for-like in FY2025 (nearly +15% over 2 years). Nursing homes led the expansion with revenue up +8.1% YoY; clinics were more muted (+2.5%). Growth drivers were a +3.3ppt price effect, +1.8ppt occupancy effect and +1.0% from ramp-up of new facilities.
Occupancy recovery
Average occupancy rose by ~1.8 percentage points to 87.6% (end-2025 vs end-2024). Nursing homes occupancy increased ~2.0ppt to 87.2% and is ~5ppt higher versus 2023; overall improvement since 2021 is ~7.6ppt.
Substantial margin and EBITDA improvements
Like-for-like EBITDA growth beat guidance at +19% for FY2025. EBITDA before IFRS16 rose by €135m (+58.3% like-for-like). EBITDAR also reported strong growth (management cited +58%), with H2 showing continued momentum.
Cash flow turnaround and large free cash flow
Net operating cash flow improved from €15m in FY2024 to €190m in FY2025. Free cash flow turned positive at €347m versus -€298m a year earlier (improvement >€600m). Recurring free cash flow was positive in H2 at €20m.
Successful disposal program and liquidity added
Disposals since mid-2022 reached €2.35bn (exceeding the prior €1.5bn target). Disposals closed in 2025 totaled ~€602m, with ~€216m signed but not yet cashed. The Isemia transaction (closed 14 Jan) added ~€703m liquidity.
Major deleveraging and refinancing completed
Entire bank debt refinanced with €3.15bn of new financing (Euribor 3M +247bps cash / +363bps incl. PIK). Pro forma net debt fell by ~€1.0bn year-over-year to ~€3.8bn; reported net debt (ex IFRS5/16) €4.5bn. Leverage improved to 9.9x pro forma (from ~19.5x prior year).
Quality, ESG and operational KPIs improved
Real estate portfolio valued at €5.6bn; 44% of beds owned. French resident satisfaction reached 93.4% (+50bps vs 2024; >+3.0pts vs 2022). Net Promoter Score rose to 41 (+4 vs 2024; +23 vs 2022). Employee engagement launched at 62%; employee turnover declined. Energy consumption down ~9% YoY.
Confident near-term guidance
Company reaffirmed medium-term guidance and expects EBITDA to grow at least +10% in 2026 at constant perimeter and an average CAGR >15% for 2024–2026. Management expects continued operational leverage to support margins.

Orpea SA (FR:EMEIS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

FR:EMEIS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Sep 30, 2026
2026 (Q2)
- / -
-0.853
Apr 08, 2026
2025 (Q4)
- / -0.99
-0.963-3.22% (-0.03)
Sep 30, 2025
2025 (Q2)
- / -0.85
1.71-149.88% (-2.56)
Apr 16, 2025
2024 (Q4)
- / -0.96
495.709-100.19% (-496.67)
Oct 03, 2024
2024 (Q2)
- / 1.71
-366.38100.47% (+368.09)
Apr 17, 2024
2023 (Q4)
- / 495.71
-3713.747113.35% (+4209.46)
Oct 11, 2023
2023 (Q2)
- / -366.38
-266.182-37.64% (-100.20)
May 12, 2023
2022 (Q4)
- / -3713.75
-36.755-10004.06% (-3676.99)
Sep 28, 2022
2022 (Q2)
- / -266.18
101.206-363.01% (-367.39)
May 13, 2022
2021 (Q4)
- / -36.76
86.044-142.72% (-122.80)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

FR:EMEIS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 08, 2026
€14.08€15.06+6.96%
Sep 30, 2025
€14.00€14.76+5.43%
Apr 16, 2025
€11.50€11.61+0.96%
Oct 03, 2024
€5.25€5.70+8.61%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Orpea SA (FR:EMEIS) report earnings?
Orpea SA (FR:EMEIS) is schdueled to report earning on Sep 30, 2026, TBA (Confirmed).
    What is Orpea SA (FR:EMEIS) earnings time?
    Orpea SA (FR:EMEIS) earnings time is at Sep 30, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Orpea SA stock?
          The P/E ratio of Orpea SA is N/A.
            What is FR:EMEIS EPS forecast?
            Currently, no data Available